Dr Reddys Analysts Recommendations and Consensus

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:4em;padding-top: 25px;;'>DR</div>
RDY -- USA Stock  

USD 45.45  0.40  0.87%

The current analyst and expert consensus on Dr Reddys is Hold with 0 strong sell and 1 strong buy opinions. The current projected target price consensus is 48.95 with 2 analysts opinions. The most common way Dr Reddys Laboratories analysts use to provide recommendation to public is financial statements analysis. Many experts also interview Dr Reddys executives and customers to further validate their buy or sell advice. Please note, the number of analysists providing the opinion is not sufficient to provide adequate consensus on Dr Reddys. We encourage you to use your own analysis of Dr Reddys Laboratories to validate this buy or sell advice. Dr Reddys buy or sell recommendation module provides average expert sentiment on the projected Dr Reddys Laboratories target price to derive its highest and lowest estimates based on projected price volatility of 9.97. Additionally take a look at Macroaxis Advice on Dr Reddys to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

Dr Reddys Target Price Consensus

Number of Opinions2
Lowered Outlook0
Raized Outlook0
Macroaxis Recommendation   Exposure   Valuation

Dr Reddys Target Price Projection

Current Price

Dr Reddys Market Quote

Low Price45.27Odds
High Price46.01Odds


Target Price

Analyst Consensus On Target Price

Low Estimate41.9Odds
High Estimate56.0Odds
Number of Analysts2
Standard Deviation9.97


Dr Reddys Analysit Ratings

Average Consensus